000 01323 a2200373 4500
005 20250514214936.0
264 0 _c20050527
008 200505s 0 0 eng d
022 _a1469-493X
024 7 _a10.1002/14651858.CD003685.pub2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGarner, S E
245 0 0 _aRofecoxib for rheumatoid arthritis.
_h[electronic resource]
260 _bThe Cochrane database of systematic reviews
_cJan 2005
300 _aCD003685 p.
_bdigital
500 _aPublication Type: Journal Article; Review; Systematic Review
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xadverse effects
650 0 4 _aArthritis, Rheumatoid
_xdrug therapy
650 0 4 _aCyclooxygenase Inhibitors
_xadverse effects
650 0 4 _aDrug Approval
650 0 4 _aHumans
650 0 4 _aLactones
_xadverse effects
650 0 4 _aNaproxen
_xadverse effects
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aSulfones
_xadverse effects
700 1 _aFidan, D D
700 1 _aFrankish, R R
700 1 _aJudd, M G
700 1 _aTowheed, T E
700 1 _aWells, G
700 1 _aTugwell, P
773 0 _tThe Cochrane database of systematic reviews
_gno. 1
_gp. CD003685
856 4 0 _uhttps://doi.org/10.1002/14651858.CD003685.pub2
_zAvailable from publisher's website
999 _c15352815
_d15352815